- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03473808
Functional Connectivity & Stimulation-enhanced Therapy Post Stroke
March 1, 2019 updated by: Na Jin Seo, Medical University of South Carolina
Brain Functional Connectivity & Sensory Stimulation-enhanced Therapy Post Stroke
After stroke, it is common for individuals to experience hand impairment.
This deficit can severely restrict functional ability and independence.
Recovery of hand function following stroke is highly variable.
In this study, the investigators will use brain imaging to predict individual response to treatment.
Survivors of stroke will receive upper extremity therapy while they concurrently receive imperceptible vibration to the wrist aimed to enhance therapy outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The ability to predict individuals' responses to treatment can enable effective allocation of a treatment to likely responders.
The long-term goal is to determine whether acute changes in brain functional connectivity immediately after one treatment session can predict ultimate gains in motor function after completing multiple treatment sessions.
The objective of this study is to determine feasibility and to examine association between change in brain functional connectivity after one session and motor gains after completion of all treatment sessions.
This study is a prospective single-cohort longitudinal study.
The treatment is task-practice therapy (3d/wk, 18-session) accompanied with concurrent imperceptible wrist vibration that is intended to prime the cortical sensorimotor network and enhance hand functional recovery in chronic stroke survivors.
Hand function will be assessed before/after therapy and at 1-month follow-up.
Connectivity will be assessed using fMRI and EEG before and after a treatment session.
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29403
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age = 18 or older
- At least 6 months post-stroke
- Moderate upper limb impairment with the ability to participate in hand task practices
- Fingertip touch sensory deficits (e.g., Monofilament>2.83, 2-point discrimination>5mm, sense of numbness, tingling)
Exclusion Criteria:
- Complete upper limb deafferentation
- Rigidity (Modified Ashworth Scale=5)
- Botulinum toxin injection within 3 months prior to enrollment or during enrollment
- Brainstem stroke
- Comorbidity (peripheral neuropathy, orthopaedic conditions in the hand that limit ranges of motion, premorbid neurologic conditions, compromised skin integrity of the hand/wrist due to long-term use of blood thinners)
- Concurrent upper extremity rehabilitation therapy
- Language barrier or cognitive impairment that precludes following instructions or providing consent
- MRI incompatible.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: therapy + vibration
Imperceptible vibration applied to the wrist during a standardized hand task practice therapy program.
|
Standardized hand therapy program
Peripheral vibration applied to the wrist skin at an imperceptible level
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change in Hand Motor Function
Time Frame: Baseline to approximately 1 week after the completion of 18 therapy sessions.
|
Change in hand motor function as measured by the Box and Block Test.
The test measures the number of blocks that a participant moves within one minute.
The scale ranges from 0 to a positive number.
Higher numbers represent better outcomes.
|
Baseline to approximately 1 week after the completion of 18 therapy sessions.
|
Mean Change in Hand Motor Function
Time Frame: Baseline to approximately 4 weeks after the completion of 18 therapy sessions.
|
Change in hand motor function as measured by the Box and Block Test.
The test measures the number of blocks that a participant moves within one minute.
The scale ranges from 0 to a positive number.
Higher numbers represent better outcomes.
|
Baseline to approximately 4 weeks after the completion of 18 therapy sessions.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change in Hand Motor Function
Time Frame: Baseline to approximately 1 week after the completion of 18 therapy sessions.
|
Change in hand motor function as measured by the Wolf Motor Function Test Time.
This test measures time to complete upper extremity movements in seconds.
More negative values represent a greater reduction in time, thus better outcomes.
|
Baseline to approximately 1 week after the completion of 18 therapy sessions.
|
Mean Change in Hand Motor Function
Time Frame: Baseline to approximately 4 weeks after the completion of 18 therapy sessions.
|
Change in hand motor function as measured by the Wolf Motor Function Test Time.
This test measures time to complete upper extremity movements in seconds.
More negative values represent a greater reduction in time, thus better outcomes.
|
Baseline to approximately 4 weeks after the completion of 18 therapy sessions.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Steve Kautz, PhD, Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 7, 2018
Primary Completion (Actual)
September 24, 2018
Study Completion (Actual)
September 24, 2018
Study Registration Dates
First Submitted
March 5, 2018
First Submitted That Met QC Criteria
March 15, 2018
First Posted (Actual)
March 22, 2018
Study Record Updates
Last Update Posted (Actual)
March 5, 2019
Last Update Submitted That Met QC Criteria
March 1, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO74041
- U54GM104941 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on task-practice therapy
-
VA Office of Research and DevelopmentMedical University of South CarolinaCompleted
-
Adventist HealthCareTexas Woman's UniversityCompletedStroke | Upper Extremity ParesisUnited States
-
US Department of Veterans AffairsWithdrawnHemiplegia | Cerebrovascular Accident
-
The Cleveland ClinicUnited States Department of DefenseRecruitingCervical Spinal Cord InjruyUnited States
-
Ohio State UniversityCompletedStroke | HemiparesisUnited States
-
The Cleveland ClinicAmerican Heart AssociationCompleted
-
VA Office of Research and DevelopmentNot yet recruiting
-
University of WashingtonRecruitingSpinal Cord InjuriesUnited States